Prazosin Dosing for PTSD-Related Nightmares
Start prazosin at 1 mg at bedtime, increase by 1–2 mg every few days until nightmares resolve, targeting 3–4 mg/day in civilians or 10–16 mg/day in military veterans, with blood pressure monitoring after the initial dose and each significant increase. 1, 2
Starting Dose and First-Dose Precautions
- Initiate with 1 mg at bedtime to minimize the risk of first-dose orthostatic hypotension 1, 2, 3
- Monitor blood pressure after the first dose, particularly in elderly patients or those on concurrent antihypertensive medications 1
- Lower starting doses are warranted in older adults due to increased sensitivity to alpha-1 blockade 1
Titration Schedule
- Increase by 1–2 mg every few days based on nightmare frequency reduction and blood pressure tolerance 1, 2
- Continue titration until nightmares are absent or adequately reduced, or until the maximum recommended dose is reached 2
- Assess nightmare frequency using standardized measures such as the CAPS distressing-dreams item (score ≥4/8 indicates treatment indication) 4
Target Dose Ranges by Population
Civilian PTSD Patients
- Average effective dose: 3–4 mg/day (mean 3.1 ± 1.3 mg) 1
- Most civilian patients achieve clinical response within this range without requiring higher doses 1
Military Veterans with Combat-Related PTSD
- Average effective dose: 9.5–15.6 mg/day 1, 2
- Veterans consistently require substantially higher doses than civilians, likely due to greater trauma severity and chronicity 1
- Gender differences exist in military populations: men require mean doses of 15.6 ± 6.0 mg while women require 7.0 ± 3.5 mg 1
Maximum Recommended Doses
- Standard maximum: 20 mg at bedtime for most patients 2, 3
- Some treatment-resistant cases have tolerated doses up to 30–45 mg daily, though this exceeds typical guideline recommendations 5
- The 10–20 mg/day range represents the upper limit studied in most clinical trials and balances efficacy with safety 1
Administration Timing
- Single bedtime dose is the standard initial approach for nightmare management 1
- For severe daytime flashbacks or breakthrough symptoms, consider divided dosing (e.g., morning and bedtime doses) given prazosin's 2–3 hour half-life 6
- One regimen used in military personnel: 5 mg mid-morning plus 20 mg at bedtime 2
Blood Pressure Monitoring Protocol
- Check blood pressure after the initial 1 mg dose 1
- Recheck with each significant dose increase (every 2–4 mg increment) 1
- Transient orthostatic hypotension is common but usually resolves during continued treatment 1
- Dizziness and lightheadedness are the most frequent side effects, particularly after initial doses 1
Critical Drug Interaction
Concurrent SSRI or SNRI use may substantially reduce prazosin efficacy. 4
- In one military trial, patients on SSRIs showed mean CAPS score improvement of only 9.6 points versus 30.1 points in those not on SSRIs 4
- In the 2018 VA trial showing no prazosin benefit, 78% of participants were on maintenance antidepressants, potentially explaining the negative result 4
- Consider this interaction when planning treatment; prazosin may still be attempted but expect potentially diminished response 1, 4
Treatment Response Assessment
- Track nightmare frequency and distress using sleep diaries and standardized instruments 4
- Clinical response typically occurs within weeks of reaching therapeutic dose 3
- Nightmares return to baseline intensity if prazosin is discontinued—this is suppressive therapy, not curative 1, 4
Common Pitfalls to Avoid
- Do not use prazosin as a general anxiolytic—it is specifically indicated for trauma-related nightmares, not generalized anxiety 4
- Do not undertitrate in military veterans; they require substantially higher doses than civilians 1, 2
- Do not ignore the SSRI interaction; document concurrent antidepressant use and adjust expectations accordingly 4
- Do not discontinue abruptly without counseling patients that nightmares will recur 1
Alternative if Prazosin Causes Panic
If prazosin induces panic attacks (rare but reported), switch to topiramate starting at 12.5–25 mg daily, titrating by 25–50 mg every 3–4 days to a target of ≤100 mg/day, which achieves full response in 91% of patients and complete nightmare suppression in 50% 4